Candesic Revenue and Competitors
Estimated Revenue & Valuation
- Candesic's estimated annual revenue is currently $13.1M per year.
- Candesic's estimated revenue per employee is $198,000
Employee Data
- Candesic has 66 Employees.
- Candesic grew their employee count by 0% last year.
Candesic's People
Name | Title | Email/Phone |
---|---|---|
1 | Engagement Manager | Reveal Email/Phone |
2 | Senior Office Manager | Reveal Email/Phone |
3 | People Manager | Reveal Email/Phone |
4 | Human Resources Manager | Reveal Email/Phone |
5 | Senior Advisor | Reveal Email/Phone |
6 | Senior Data Analyst | Reveal Email/Phone |
7 | Business Analyst | Reveal Email/Phone |
8 | Associate Principal | Reveal Email/Phone |
9 | Software Engineer | Reveal Email/Phone |
10 | Partner | Reveal Email/Phone |
Candesic Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.1M | 1 | 0% | N/A | N/A |
#2 | $57.6M | 238 | 28% | N/A | N/A |
#3 | $334.5M | 1086 | 43% | N/A | N/A |
#4 | $259.2M | 824 | 28% | $346M | N/A |
#5 | $13.1M | 66 | 0% | N/A | N/A |
#6 | $50.1M | 207 | 47% | N/A | N/A |
#7 | $19.8M | 90 | 7% | N/A | N/A |
#8 | $2M | 15 | -21% | N/A | N/A |
#9 | $57.6M | 238 | 2% | N/A | N/A |
#10 | $7.9M | 45 | 5% | N/A | N/A |
What Is Candesic?
Candesic provides management consultancy and commercial due diligence services to corporates, private equity and other financial investors, and public sector organisations like the NHS. Our main practices are healthcare and social care, aerospace, defence & security. Candesic was founded in 2002 by Dr Leonid Shapiro and Marc Kitten. The firm is headquartered in London, United Kingdom with additional offices in France, Spain, Italy and India. Commercial Due Diligence (Recent successful Transactions) Acquisition of SERB Pharmaceuticals, valued at 250m according to Mergermarket, by Charterhouse Minority investment in Lucid Group by LDC Acquisition of Carling Group by LDC-owned Fishawack Acquisition of Envision Pharma by Ardian and GHO Capital Acquisition of Priory and Partnerships in Care by BC Partners £320m Acquisition of Orolia by Eurazeo for 100m (public source) Reverse acquisition of Mediclinic by Al Noor for £7.4bn Investment in CEVA Santé Animale by CHD Investments valuing the company over 1.5bn Acquisition of Medical Imaging Partnership by Apposite Capital Metric Capital: investment in Proton Beam Therapy technology Historical transactions AllianceBoots: completed CDD for largest European LBO to date at £12bn Acquisition of Phadia by Cinven for 1.2bn (later sold to Thermo Fisher Scientific for £2.2bn) VCDD Swanton Care: provider of residential care specialised in learning disabilities and Autism Cambian: leading Mental Health provider for patients with Learning Disabilities and Acquired Brain Injuries Danshell: refinancing Strategy Caring Home Group, HC One, HCP REIT, Monarch Alternative Capital: commercial analysis of care homes site Somed: building a private hospital chain in Morocco Bupa: dental market review and strategic options for growth, led to the creation of a leading chain in the UK Schoen Klinik: spanish hospital market workshop GenesisCare: commercial integration of IMO, a Spanish radiotherapy chain
keywords:N/AN/A
Total Funding
66
Number of Employees
$13.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Candesic News
I worked with Gonçalo at Candesic for many years, Connell said. After he moved to the UK four years ago, built up his team and managed a...
... issue share to Waterland (Shoosmiths, Clearwater International, Addleshaw Goddard, Deloitte, PwC, Candesic, GK Strategy, Baldwins)
The winners, who were initially short-listed in February, included Candesic, CIL, Deloitte and Knight Frank, who were recognised by clients in ...
... all of which have seen their waiting time plummet to an average of four minutes, according to Candesic, an independent consulting firm.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.1M | 66 | 40% | N/A |
#2 | $13.5M | 66 | -3% | N/A |
#3 | $8.6M | 66 | 29% | N/A |
#4 | $8.6M | 66 | -16% | N/A |
#5 | $7.5M | 66 | -12% | N/A |